Literature DB >> 32474283

A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesion.

Takuya Ataka1, Noriyuki Kimura2, Etsuro Matsubara2.   

Abstract

We report the case of a patient with myelin oligodendrocyte glycoprotein (MOG)- antibody-associated disease presenting with tumefactive demyelinating lesion. Neurological examination showed aphasia, acalculia, agraphia, alexia, left-right disorientation, and right hemiplegia. Brain magnetic resonance imaging revealed a large monofocal lesion with mild brain edema and ring enhancement. Stereotactic brain biopsy was performed, and neuropathological findings showed inflammatory demyelination and preserved axons without tumor cells. A cell-based assay detected anti-MOG antibody in the cerebrospinal fluid. Neurological symptoms gradually improved after steroid pulse therapy. MOG-antibody-associated diseases should be considered in the differential diagnosis of tumefactive demyelinating lesion.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biopsy; Eosinophil; MOG; Pathological; Steroid therapy; Tumefactive demyelinating lesion

Mesh:

Substances:

Year:  2020        PMID: 32474283     DOI: 10.1016/j.msard.2020.102191

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  3 in total

Review 1.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

2.  Tumefactive Demyelination-A Rare Presentation of Anti-MOG Syndrome.

Authors:  Sesh Sivadasan; Rajalakshmi Poyuran
Journal:  Ann Indian Acad Neurol       Date:  2021-04-21       Impact factor: 1.383

3.  Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies.

Authors:  Jingsi Wang; Zhandong Qiu; Dawei Li; Xixi Yang; Yan Ding; Lehong Gao; Aihua Liu; Yang Song; Cunjiang Li; Ran Gao; Lin Wang; Liyong Wu; Longfei Jia; Dongmei Guo; Aihong Zhou; Jianping Jia; Liyuan Huang; Miao Qu; Li Gao; Huiqing Dong; Junwei Hao; Zheng Liu
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.